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Abstract 
Background: Identifying the connection among diet, the intestinal microbiome, and host health is currently an area 
of intensive research, but the potential of dietary fiber (DF) consumption to ameliorate intestinal inflammation has 
not been extensively studied. We examined the impacts of the DFs, wheat bran (WB) and resistant starch (RS) on host 
enteric health. A murine model of acute Th1/Th17 colitis (i.e. incited by Citrobacter rodentium) was used.
Results: Diets enriched with RS increased weight gain in mice inoculated with C. rodentium compared to mice 
consuming a conventional control (CN) diet. Short-chain fatty acid (SCFA) quantities in the cecum and distal colon 
were higher in mice consuming DFs, and these mice exhibited higher butyrate concentrations in the distal colon 
during inflammation. Histopathologic scores of inflammation in the proximal colon on day 14 post-inoculation (p.i.) 
(peak infection) and 21 p.i. (late infection) were lower in mice consuming DF-enriched diets compared to the CN diet. 
Consumption of WB reduced the expression of Th1/Th17 cytokines. As well, the expression of bacterial recognition 
and response genes such as Relmβ, RegIIIγ, and Tlr4 increased in mice consuming the RS-enriched diets. Furthermore, 
each diet generated a region-specific bacterial community, suggesting a link between selection for specific bacterial 
communities, SCFA concentrations, and inflammation in the murine colon.
Conclusions: Collectively, data indicated that the consumption of DF-rich diets ameliorates the effects of C. roden-
tium-induced enteritis by modifying the host microbiota to increase SCFA production, and bacterial recognition and 
response mechanisms to promote host health.
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Background
The intestine is highly influential to host health and 
contributes greatly to the balance and regulation of the 
host intestinal immune system and the microbiome. The 
association between the quality of foods consumed and 
the severity of intestinal diseases has become a topic of 
scientific interest, and diets rich in dietary fibers (DFs) 
are suggested to reduce intestinal inflammation [1, 2]. 
Dietary fibers are defined as carbohydrates with three or 
more polymerized saccharide units that resist digestion 
in the small intestine by host-derived intestinal enzymes, 
and are only susceptible to fermentation by bacteria in 
the intestine [3]. They differ from one another in their 
water solubility, viscosity, and effects on the intestinal 
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microbiota [4, 5]. Fermentation rates can vary depend-
ing on the chemical structure of DFs, and characteristics 
such as chain length, quantity of saccharide units, and 
the number of sugar linkages regulate the efficiency of 
carbohydrate fermentation [6]. Certain enteric bacterial 
species possess specialized metabolic enzymes that fer-
ment specific forms of DFs, and products of fermentation 
contribute to the bacterial diversity within the intestinal 
microbiota [4, 7, 8]. By-products of bacterial fermen-
tation are mainly composed of short-chain fatty acids 
(SCFAs) such as acetate, propionate, and butyrate [9, 
10] as well as gases. Acetate and propionate are primar-
ily metabolized in the liver and are important for gluco-
neogenesis and liponeogenesis [11]. In contrast, butyrate 
is a primary energy source for colonocytes, and it is also 
thought to enhance mucus production and regulate 
intestinal immune function [12]. Other putative func-
tions of SCFAs within the intestine include maintaining 
homeostatic intestinal pH and mucosal osmolarity [10], 
and influencing mucin production and secretion [13], all 
of which are considered important for both cellular and 
microbial functions.
Resistant starches (RSs) are highly soluble and readily 
fermented fibers that produce high quantities of butyrate 
following bacterial fermentation [14]. Resistant starch 
is primarily comprised of amylose and branched-amy-
lopectin carbohydrate units, and exist as many complex 
structures that differ in their accessibility to enzymatic 
digestion [9]. The digestion of RS by intestinal bacteria 
can affect the structure of the microbiota within the large 
intestine, and RS fermentation often leads to an increase 
in Bifidobacterium spp., Parabacteroides spp., Rumino-
coccus spp., and Eubacterium spp. [15, 16]. The microbial 
fermentation of RS increases intestinal SCFA concentra-
tions, which lower the intestinal pH to modulate bacterial 
growth, and increase water and ion uptake to counter the 
losses experienced during diarrheic events [17]. Further-
more, the fermentation of high amylose starch has been 
associated with influencing muscular contractions in the 
large intestine that increases the blood flow in viscera and 
counters the negative effects of diarrhea [17]. Wheat bran 
(WB) is a DF that is not as easily fermented when com-
pared to RS, but its fermentation can lead to an increase 
in overall SCFA production in the intestine [18]. Wheat 
bran is a complex molecule composed mainly of insolu-
ble non-starch polysaccharides, including arabinoxylan, 
cellulose, and β-glucan fractions that comprise ≈46% of 
its total fiber content [5, 19]. The complex structure and 
low percentage of soluble fiber present in WB contrib-
utes to slower fermentation rates by intestinal bacteria, 
and as such, is important for the increase in fecal bulking 
and stool frequency [20]. The fermentation of WB also 
improves intestinal lipid profiles that may lower the risk 
of intestinal cancer development [4, 7, 21]. Similarly to RS 
digestion, bacterial fermentation of WB can affect bacte-
rial communities within the intestine. For example, fer-
mentation of WB increases the abundance of Clostridia 
cluster XIVa, including butyrogenic bacteria such as Fae-
calibacterium prausnitzii and Roseburia intestinalis [22]. 
Although RS and WB both alter the intestinal microbiota 
and affect intestinal function by increasing water uptake 
and fecal bulking respectively, these DFs appear to influ-
ence the intestinal environment and immune response in 
different ways. Thus, we chose to examine the impacts of 
both RS and WB on the enteric microbiota and host to 
elucidate key aspects of the relationship among diet, host 
responses, and inflammation.
Citrobacter rodentium is a Gram negative bacterium 
that incites epithelial cell hyperplasia and inflammation 
within the murine colonic mucosa, and it is commonly 
used to study intestinal inflammation in mice [23]. Colitis 
incited by C. rodentium is a self-limiting process in mice, 
with peak infection occurring ≈7–14 days post-inocula-
tion (p.i.) and disease resolution occurring ≈28 days p.i. 
[24], although disease can be prolonged up to 3–4 weeks 
p.i. [25]. C. rodentium induced tissue injury is associated 
with transmural inflammatory changes, and once the 
bacterium breaches the mucosa it subsequently invades 
the underlying tissue [26–28]. Infections with C. roden-
tium induce a pro-inflammatory immune response that is 
characterized by an initial Th17 response, followed by a 
Th1 response towards recovery [27, 29]. This bacterium 
is commonly used as an inducer of acute inflammation in 
the murine intestine [23], but few studies have examined 
the impacts of DFs on the pathobiology of C. rodentium-
induced intestinal inflammation. Generally, research 
investigating the therapeutic potential of DFs has focused 
on the alterations to the microbiota in models that do not 
exhibit acute inflammation [30–32]. A number of stud-
ies have investigated the effects of DFs on the host using 
inflamed enteric models. However, these studies have 
primarily induced inflammation using chemical incit-
ants [33–37], and very few studies have used a bacterial 
incitant to induce intestinal dysbiosis [38]. In the cur-
rent study, we examined the effects of the DFs, RS and 
WB collectively on the intestinal microbiota and the host, 
with an emphasis on the host immune response following 
challenge with C. rodentium as a Th1/Th17 inflammation 
incitant. We hypothesized that DFs will increase bacterial 
fermentation and SCFA concentrations within the large 
intestine of mice. This will stimulate enhanced mucus 
secretion, alter luminal bacterial communities including 
selection for butyrogenic taxa, and modulate the intesti-
nal immune response to ameliorate intestinal inflamma-
tion. We further hypothesized that as RS will be more 
readily fermented than WB, the fermentation of RS will 
Page 3 of 20Jiminez et al. Gut Pathog  (2016) 8:67 
contribute to an increased amount of intestinal butyrate, 
and thereby differentially increase mucin secretion to 
reduce C. rodentium-induced mucosal injury.
Results
Citrobacter rodentium incited enteritis
The presence of C. rodentium was not detected in the 
feces of mice inoculated with phosphate buffered saline 
(PBS). In contrast, mice in all treatment groups inocu-
lated with C. rodentium exhibited the highest (P = 0.001) 
levels of shedding on days 3–10 p.i. (Fig.  1). Mice con-
suming the WB and RS diets shed the highest amount 
of C. rodentium on day 7 p.i., while mice ingesting the 
control (CN) diet shed the highest counts of C. roden-
tium on day 10 p.i. (Fig. 1). Mice consuming the WB diet 
shed C. rodentium at higher quantities than mice ingest-
ing the CN (P = 0.004) and RS (P = 0.005) diets. Densi-
ties of C. rodentium in feces steadily decreased for all diet 
treatments after day 10 p.i. At the later stages of infection 
(>14 days p.i.), a trend (P = 0.168) of lower C. rodentium 
densities in the feces was observed in mice consuming 
the WB diet in comparison to the RS and CN diet treat-
ment mice.
Histopathologic changes and colon length in mice 
with enteritis
Mice without enteritis exhibited total average histo-
pathological scores of ≤1.75  ±  0.48 in the proximal 
colon, and ≤1.25 ± 0.63 in the distal colon; furthermore, 
these mice did not show clinical manifestations of intes-
tinal disease or signs of infection (Additional file 1: Fig-
ure S1, S2). Mice inoculated with C. rodentium exhibited 
substantially higher histopathologic scores (P  ≤  0.001) 
relative to mice inoculated with PBS for all of the catego-
ries examined. Histopathologic evidence of acute inflam-
mation incited by C. rodentium was observed in both the 
proximal (Fig. 2) and distal (Additional file 1: Figure S3) 
colon. The degree of cellular injury was highest on day 14 
p.i. (i.e. peak infection) and day 21 p.i. (i.e. late infection), 
and decreased by day 28 p.i. (i.e. clearance) (Fig.  2a–f). 
Histopathologic scores of cellular injury in the distal 
colon were similar (P  ≥  0.322) among the diet treat-
ments for mice with enteritis (Additional file  1: Figure 
S3A–G). However, in the proximal colon, mice fed the 
WB diet (P =  0.029) showed altered histological scores 
overall as compared to those fed the CN diet (Fig. 2a–f). 
Specifically, mice fed the WB diet displayed lower meas-
ures of epithelial cell hyperplasia (P = 0.035), goblet cell 
depletion (P =  0.018), epithelial cell injury (P =  0.027), 
mitotic activity (P = 0.032), crypt height (P = 0.024), and 
a lower total score of inflammation (P = 0.029) than the 
CN diet treatment mice. Mice fed the RS diet displayed 
a trend of reduced (P  =  0.093) goblet cell depletion in 
comparison to mice consuming the CN diet. Averaged 
over time, mice consuming the RS diet also had longer 
(P = 0.015) colons in comparison to the CN and WB diet 
mice (Fig. 3). Overall, mice consuming diets high in DF 
displayed lower scores of inflammation in the proximal 
colon, in comparison to the distal colon.
Food consumption and weight gain in mice
Diet treatment had no effect (P = 0.285) on the amount 
of food consumed in mice without enteritis (Fig.  4a). 
However, mice with enteritis administered the WB diet 
consumed less (P =  0.030) food than those fed the CN 
diet (Fig. 4b). In all mice, the average final weights of mice 
steadily increased (P < 0.001) over the 28-day experimen-
tal period (Fig. 4c, d). In mice without enteritis (Fig. 4c), 
individuals consuming the RS diet gained weight more 
rapidly (P =  0.017) than those consuming the CN diet. 
Mice with enteritis gained less (P < 0.001) weight overall 
in comparison to mice without enteritis.
Short‑chain fatty acid concentrations in the cecum 
and distal colon
Short-chain fatty acid concentrations were measured in 
the cecum, proximal colon, and distal colon, and quan-
tities of total SCFAs differed between these locations 
(Fig.  5a–c). Generally, the highest quantities of total 
SCFAs were observed in the cecum and distal colon. Con-
centrations of total SCFAs (P < 0.001), and butyrate spe-
cifically (P = 0.003) were higher in mice without enteritis 
than in mice with enteritis in the distal colon (Fig. 5c, d). 
Fig. 1 Densities of Citrobacter rodentium (CFU/g) in feces from mice 
inoculated with the bacterium over a 28 day period consuming a 
control diet (CN), or a diet enriched with wheat bran (WB) or resistant 
starch (RS). Vertical lines associated with markers represent the stand-
ard error of the mean (n = 3); where error bars are not visible, varia-
tion is minimal and obscured by the marker. **Different (P ≤ 0.010) 
from the CN treatment
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In the cecum, enteritis had no effect on total SCFA con-
centrations (P  =  0.497) (Fig.  5a). However, total SCFA 
(P  =  0.008) (Fig.  5a), acetate (P  =  0.013) (Additional 
file  1: Table S1), and butyrate (P  <  0.001) (Additional 
file  1: Table S1) were all affected by the diet treatment. 
Butyrate concentrations in the cecum were higher for the 
WB diet than the CN (P < 0.001) and RS (P = 0.009) diet 
treatments (Additional file 1: Table S1). In the proximal 
colon, mice fed the WB diet exhibited higher (P = 0.051) 
overall concentrations of SCFAs as compared to those 
fed the RS and CN diets (Fig. 5b) (Additional file 1: Table 
S1). In the distal colon, concentrations of total SCFAs 
Fig. 2 Histological scores measured in the proximal colons of mice inoculated with C. rodentium (CR+) consuming a control diet (CN), or a diet 
enriched with wheat bran (WB) or resistant starch (RS). a Epithelial cell hyperplasia. b Crypt height. c Epithelial cell injury. d Goblet cell depletion. e 
Mitotic cell activity. f Total average histological scores. Vertical lines associated with histogram bars represent the standard error of the mean (n = 4). 
#Different (P ≤ 0.100) from the CN treatment. *Different (P ≤ 0.050) from the CN treatment. Statistical analyses are representative of scores averaged 
over all time points
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(P < 0.001), acetate (P < 0.001), propionate (P =  0.002), 
and butyrate (P  =  0.003) were substantially reduced in 
mice with enteritis at the peak, late, and clearance stages 
of infection (Fig.  5c) (Additional file  1: Table S1). Fur-
thermore, mice consuming the WB (P =  0.005) and RS 
(P = 0.053) diets showed higher butyrate concentrations 
as compared to those consuming the CN diet (Fig. 5a–c). 
In mice without enteritis, butyrate concentrations in 
mice consuming the WB diet were higher (P = 0.001) rel-
ative to the CN diet treatment in the distal colon (Fig. 5d) 
(Additional file 1: Table S1).
Mucus accumulation
The accumulation of mucus in the distal colon of mice 
without enteritis did not differ between the diets (Addi-
tional file  1: Figure S4). Mucus accumulation in goblet 
cells and to a lesser extent within the intestinal lumen 
of mice with enteritis was marginally increased for mice 
consuming the WB diet (Fig. 6b, e, h) as compared to the 
CN diet (Fig. 6a, d, g). Increased mucus accumulation in 
the goblet cells was also observed in mice consuming the 
RS diet (Fig.  6c, f, i) relative to the CN diet (Fig.  6a, d, 
g) at the clearance stage of infection. Mice with enteri-
tis exhibited reduced expression of Muc2 as compared 
to mice without enteritis (P < 0.001) (Fig. 7d) (Additional 
file 1: Figure S4). At peak infection, it was observed that 
RS diet treatment mice exhibited the highest (P = 0.043) 
expression of Muc2 in the distal colon (Fig. 7d) as com-
pared to the CN diet; however by late infection, there was 
no difference (P = 0.387) between the two treatments.
Expression of immune regulation and bacterial recognition 
genes
In mice without enteritis, there was no effect (P ≥ 0.100) 
of diet on the expression of Th1 (Il-1β, Ifnγ, Tnfα) or 
Th17 (Il-17A, Il-22, Il-23A) associated cytokines, Treg 
(Il-10, Tgfβ), mucus associated (Muc2, Tff3, Relmβ), or 
bacterial recognition (Tlr2, Tlr4, Myd88, RegIIIγ) genes 
(Additional file 1: Figure S5). In mice with enteritis, Th17 
(Il-17A) and Th1 (Il-1β, Tnfα) associated cytokine genes 
did not show changes in expression in response to DF-
enriched diets, but were highly expressed as compared 
to mice without enteritis (Fig.  7a, b, e). At peak infec-
tion, mice consuming the RS and WB diets exhibited 
the highest expression (P  =  0.040) of Tlr4 relative to 
CN diet treatment mice (Fig.  7c). For the RS diet treat-
ment, a trend of increased (P =  0.083) Tlr4 expression 
was observed in mice with enteritis relative to those con-
suming the WB diet. Mice consuming the RS diet also 
exhibited a trend towards elevated (P = 0.083) expression 
of Ifnγ during late infection, and increased (P =  0.043) 
expression of the defence cytokine, Relmβ at peak infec-
tion as compared to mice consuming the WB diet (Fig. 7f, 
j). Although not statistically significant (P > 0.050), mice 
consuming the RS diet tended to exhibit elevated expres-
sion (P ≤  0.083) of Treg cytokines (i.e. Il-10, Tgfβ), and 
this was evident during peak infection as compared 
to mice consuming the WB and CN diets, respec-
tively (Fig.  7g, h). The expression of RegIIIγ was high-
est (P =  0.016) at peak infection in all mice, and those 
consuming the WB diet exhibited the lowest expression 
of this gene (P =  0.021) relative to mice consuming the 
CN diet (Fig.  7i). Generally, mice consuming the WB 
diets displayed lower expression of bacterial recognition 
genes (Tlr4, RegIIIγ), the defense cytokine gene Relmβ, 
the Th1 regulatory cytokine gene Ifnγ, and the regulatory 
cytokine gene Il-10 during peak and late infection.
Bacterial community structures in the large intestine
The bacterial communities associated with mucosa in 
the proximal and distal colon, and within ingesta in the 
cecum were distinct from one another. Both enteri-
tis and diet affected community structure (Fig.  8). The 
Fig. 3 Average colon length (cm) in mice gavaged with PBS and 
inoculated with C. rodentium consuming a control diet (CN), or a 
diet enriched with wheat bran (WB) or resistant starch (RS) over a 
28 day period. a Mice gavaged with PBS. b Mice inoculated with C. 
rodentium. Vertical lines associated with histogram bars represent the 
standard error of the mean (n = 4). *Different (P ≤ 0.050) from the CN 
treatment
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DF treatments were associated with unique community 
structures in the proximal colon (P = 0.001), and within 
cecal ingesta (P = 0.001) (Fig. 8b, c). Although less con-
spicuous than in the proximal colon, diet also affected 
(P = 0.024) the structure of the mucosa-associated com-
munity in the distal colon (Fig.  8a). Within the distal 
colon, enteritis had a profound impact (P  =  0.006) on 
bacterial communities (Fig. 8a).
In contrast, C. rodentium infection did not alter 
(P > 0.658) community structures in the proximal colon 
or cecum. The consumption of the RS diet was associ-
ated with an increase (P = 0.005) in the abundance Rose-
buria spp. in the distal colon of mice without enteritis, 
and an increase (P =  0.034) in the abundance of Rumi-
nococcus spp. in the distal colon of mice with enteritis 
(Fig. 9a) in comparison to mice consuming the CN diet. 
The abundance of Proteobacteria in the distal colon was 
lower (P  =  0.016) in mice with enteritis as compared 
to mice without enteritis (Fig.  10a). In mice consuming 
the RS diet, an increase (P  =  0.001) in the abundance 
of Verrucomicrobia and the mucus-associated species, 
Akkermansia muciniphila was observed in the proximal 
colon (Fig. 9b). In addition, the abundance of A. mucin-
iphila was increased (P =  0.045) in the proximal colon 
of mice that consumed the WB diet, and most notably in 
mice with enteritis (Fig.  10b). Furthermore, an increase 
(P < 0.001) in the abundance of bacterial species within 
the family, Christensenellaceae was observed in the prox-
imal colon of mice without enteritis that consumed the 
RS relative to the CN diet (Fig. 9b). In the cecal ingesta 
of mice that ingested the RS diet, the abundance of spe-
cies in the Bacteroidetes phylum was reduced (P = 0.055) 
relative to the CN diet (Fig. 10c). However, in mice with-
out enteritis that consumed the RS diet, a conspicuous 
increase (P ≤  0.050) in the abundance of species in the 
Actinobacteria phylum was observed (Fig. 9c). The con-
sumption of the WB diet was associated with a change 
(P ≤ 0.050) in the abundance of bacteria within the Act-
inobacteria (i.e. Coriobacteriaceae) and Bacteroidetes 
(i.e. Porphyromonadaceae and Paraprevotellaceae) phyla 
Fig. 4 Feed consumption and final weight values in mice gavaged with PBS and inoculated with C. rodentium consuming a control diet (CN), or 
a diet enriched with wheat bran (WB) or resistant starch (RS). a Feed consumption in mice without enteritis. b Feed consumption in mice with 
enteritis. c Body weights of mice without enteritis. d Body weights of mice with enteritis. Vertical lines associated with histogram bars represent the 
standard error of the mean (n = 4) where error bars are not visible, variation is minimal and obscured by the marker. *Different (P ≤ 0.050) from the 
CN treatment
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in comparison to mice consuming the RS and CN diets 
(Fig. 9c). It is noteworthy that all species within the Ver-
rucomicrobia phylum were identified as A. muciniphila, 
while all species identified within the Deferribacteres 
phylum were identified as Mucispirillum schaedleri. As 
such, a general trend of reduced Deferribacteres and M. 
schaedleri abundance was observed in the cecal ingesta 
of mice with enteritis that consumed both the WB and 
RS diets; however, the mucus degrading A. muciniphila 
showed a trend of increased abundance in mice with-
out enteritis that consumed either the WB or RS diets 
(Fig. 10c). Finally, the abundance of butyrogenic species 
including Dorea, Ruminococcus, and Roseburia spp. was 
increased in the ceca and colons of mice with and with-
out enteritis that consumed diets enriched with WB or 
RS (Additional file 1: Figure S6).
Discussion
Understanding the mechanisms by which functional 
foods such as DFs influence the microbiota-host interac-
tion is important to identify food components that can 
potentially improve host health. This is a challenging 
objective given the requirement to use animal models, 
and the extreme complexity of the diet-microbiota-host 
interaction. Our investigation examined the effects of 
DFs on the mitigation of intestinal injury in mice with 
enteritis. We used mice fed diets enriched with RS and 
WB that were subjected to pathogen challenge with C. 
rodentium to induce inflammation. Our results demon-
strated that DFs alter bacterial communities within the 
large intestine, increase total SCFA concentrations in 
the cecum and colon, reduce inflammation, and improve 
weight gain.
Modulation of weight gain and appetite
Healthy mice consume more food and proportionally gain 
more weight in comparison to mice experiencing intes-
tinal inflammation induced by chemical and intestinal 
pathogens [39–41]. WB consumption triggers stimuli that 
promote satiation within the host [42], and we observed 
a consistent decrease in food intake by mice with and 
without enteritis consuming the WB-enriched diet. 
Fig. 5 Total short-chain fatty acid (SCFA) and butyrate concentrations in the cecum, proximal colon and distal colons of mice gavaged with PBS 
(CR−) and inoculated with C. rodentium (CR+) and consuming the control diet, or a diet enriched with wheat bran (WB) or resistant starch (RS). 
a Total SCFA concentrations in the cecum. b Total SCFA concentrations in the proximal colon. c Total SCFA concentrations in the distal colon. d 
Butyrate concentrations in the distal colon. Vertical lines associated with histogram bars represent the standard error of the mean (n = 4). *Different 
(P ≤ 0.050) from the corresponding CN treatment. ●●Difference (P ≤ 0.010) relative to CR+ mice
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RS-enriched diets have been reported to increase levels 
of glucagon-like pepetide-1 and peptide YY, which are 
secreted hormones that reduce appetite and food intake 
in human and non-human animals [43]. These hormones 
act in response to ingested nutrients, and both RS and 
WB diets are triggers to their secretion [43, 44]. Although 
we observed that food consumption was reduced in mice 
fed DF-enriched diets during infection, the final weights 
of these mice did not differ among the diets. Many stud-
ies have supported the conclusion that consumption of 
DF reduces food consumption and obesity in human 
beings [45–47]. In our study, mice with enteritis did not 
show a significant reduction in weight gain. A plausible 
explanation is that under conditions of enteric inflam-
mation, mice generally gain less weight and have less effi-
cient nutrient absorption due to cellular injury [48]. We 
observed that mice without acute enteritis that consumed 
a RS-enriched diet had higher final weights, and a longer 
colon; the increased body weight and length of the colon 
is consistent with an increase in the combined mass of 
the intestinal cells [49]. This may not only translate to 
enhanced anabolism, but improved mucosal repair, bar-
rier function and enterocyte hyperplasia, contributing to 
an increase in colon length are well-recognized manifesta-
tions of mitigated intestinal inflammation [40]. Although 
DF intake can reduce feed intake, generally, the total 
amount of calories required for growth is not affected, 
and individuals can still maintain a healthy weight [50]. 
Furthermore, highly fermentable fibers may accelerate 
fecal passage time; although decreased transit time can 
impart negative effects on the physiology of the host, it 
may also contribute to increased shedding and removal of 
bacterial pathogens [39, 51, 52]. Taken together, evidence 
indicates that the consumption of diets enriched with WB 
Fig. 6 Mucus in the distal colons of mice inoculated with C. rodentium consuming a control diet (CN), or a diet enriched with wheat bran (WB) or 
resistant starch (RS). a CN treatment on day 14 post-inoculation (p.i.), b WB treatment on day 14 p.i., c RS treatment on day 14 p.i., d CN treatment on 
day 21 p.i., e WB treatment on day 21 p.i., f RS treatment on day 21 p.i., g CN treatment on day 28 p.i., h WB treatment on day 28 p.i., i RS treatment 
on day 28 p.i. Alcian Blue stain identifies mucus staining within the colonic sections. Bar, 100 µm
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and RS reduces the amount of food necessary to maintain 
a healthy body weight in mice.
Alteration of infection severity by wheat bran and cellular 
inflammation by resistant starch
Mice inoculated with C. rodentium exhibit transmu-
ral crypt hyperplasic changes within the distal colon, 
and although tissue injury is profound, the infection 
is resolved 3–4  weeks p.i. [25]. We observed that mice 
consuming the WB-enriched diet shed more colony-
forming units (CFU)/g in feces during early infection, 
but by peak and late infection, mice shed less CFU/g as 
compared to those consuming the RS-enriched and CN 
diets. Shedding of C. rodentium can be affected by the 
Fig. 7 Expression of genes involved in the Th17, Th1, and Treg immune response as well as bacterial recognition and cellular repair genes from the 
distal colon of mice inoculated with C. rodentium (CR+) consuming a control diet (CN), or a diet enriched with wheat bran (WB) or resistant starch 
(RS). a Il-17A, b Il-1β, c Tlr4, d Muc2, e Tnfα, f Ifnγ, g Il-10, h Tgfβ, i RegIIIγ, j Relmβ. Veritcal lines associated with histogram bars represent the standard 
error of the mean (n = 3). *Pairwise differences (P ≤ 0.050) between treatments. #Pairwise differences (P ≤ 0.100) between treatments. ●●Difference 
(P ≤ 0.010) in overall expression compared to non-inflamed gene expression (Additional file 1: Figure S5). ●Difference (P ≤ 0.100) relative to non-
inflamed gene expression
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carbohydrate composition of diets. In one study, diets 
enriched with both digestible carbohydrates and non-
digestible fiber demonstrated reduced clearance of C. 
rodentium, an observation linked to altered adaptive 
immunity and intestinal bacterial community structures 
[40]. C. rodentium infection initially elicits a predomi-
nantly Th17 immune response that switches to a Th1 
response as infection progresses [27]. In mice consum-
ing the WB-enriched diet, the expression of the Th17 
cytokine, Il-17A was lower than mice consuming the RS-
enriched and CN diets during peak infection, and by late 
infection, these mice exhibited the lowest expression of 
Th1 (Il-1β, Ifnγ, Tnfα) cytokines. Furthermore, the overall 
amount of C. rodentium shed in feces was the lowest in 
mice consuming the WB-enriched diet at late infection. 
This suggests that mice ingesting the WB-enriched diet 
were less affected by infection relative to mice consuming 
the RS-enriched and CN diets, and that the administra-
tion of WB-enriched diets can reduce intestinal inflam-
mation and the host immune response by undetermined 
compound(s) that are independent of SCFA production 
[53]. Further research is needed to identify the products 
of WB fermentation that improve intestinal function and 
health. Measures of tissue injury and cellular inflamma-
tion in the colon indicated that infection in the proximal 
colon was less severe as compared to the distal colon in 
the current study. As C. rodentium mainly causes damage 
to the distal colon [25], we conclude that the ingestion of 
WB is ameliorative to inflammation in tissues that are less 
severely inflamed (i.e. in the proximal colon). Further-
more, it has been shown that DF administration does not 
influence the growth of invasive pathogens such as enter-
opathogenic Escherichia coli and C. rodentium through 
elevated Treg (Il-10, Tgfβ) cytokine expression [38]. We 
observed that genes indicative of bacterial infection and 
inducers of inflammation, namely Tlr4 and RegIIIγ were 
expressed at lower amounts in mice consuming the WB-
enriched diet compared to RS-enriched diet. TLR4 is 
involved in increasing the pro-inflammatory immune 
response through the recognition of bacterial lipopoly-
saccharide [54], and RELMβ is involved in promoting 
protective epithelial cell proliferation during C. roden-
tium infection in mice [55]. We also observed elevated 
expression of Relmβ in the distal colons of mice consum-
ing the RS-enriched diet in concert with high scores of 
epithelial cell hyperplasia, suggesting that the heightened 
histopathologic scores observed in the distal colon were 
a result of protective cell growth rather than destructive 
cell growth [55]. Furthermore, in mice gavaged with PBS 
alone, those consuming the RS-enriched diet exhibited 
elevated levels of Relmβ as well as an increase epithelial 
cell hyperplasia in the distal colon compared to mice con-
suming the WB-enriched diet. Overall, the consumption 
of DFs, namely WB was beneficial in reducing the sever-
ity of C. rodentium infection in the proximal colon, and 
this was confirmed by the lowered expression of genes 
that are hallmarks of inflammation. In the distal colon 
where infection is more severe, DF was less effective at 
reducing pathologic changes; however, the RS-enriched 
diet stimulated innate factors (i.e. Relmβ) to enhance the 
host immune response and increase cell proliferation to 
reduce tissue damage. In the current study, we limited 
our examinations to intestinal tissues and the examina-
tion of markers in serum (e.g. cytokines) may yield extra-
intestinal information on the impacts of DF digestion on 
enteric inflammation.
Intestinal short‑chain fatty acids in relation to butyrogenic 
and mucus‑associated bacteria
Intestinal SCFAs are important in the maintenance of 
colonic function and intestinal homeostasis. Accurate 
measurements of colonic SCFAs can be challenging as 
Fig. 8 Unweighted Uni-Frac comparisons of the bacterial communities in the intestines of mice gavaged with PBS (CR−) and inoculated with C. 
rodentium (CR+) consuming a control (CN) diet, or a diet enriched with wheat bran (WB) or resistant starch (RS). a Distal colon. Ellipsoids identify 
clusters of communities by infection treatment. b Proximal colon. Ellipsoids identify clusters of communities by diet treatment. c Cecum. Ellipsoids 
identify clusters of communities by diet treatment
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they are rapidly metabolized by epithelial cells in the 
large intestine [56]. Fermentation rates are highest in the 
cecum and proximal colon [57], yet our data shows that 
the proximal colon had the lowest quantities of SCFAs of 
the three sites examined. This suggests that SCFAs may 
be absorbed at a faster rate in the proximal colon than 
in the distal colon and cecum [10, 58]. In the proximal 
colon, we observed no differences in SCFA concentra-
tions between mice with and without acute enteritis. In 
contrast, SCFA concentrations were higher in the distal 
colon of mice without enteritis. Amongst these mice, 
SCFA concentrations in the distal colon were elevated in 
mice that consumed DF-enriched diets, and those ingest-
ing the WB-enriched diet specifically showed the highest 
concentrations of SCFAs. Collectively, our results suggest 
that DF consumption is most effective at increasing total 
SCFA and butyrate concentrations and contributing to 
host health in the non-inflamed or moderately inflamed 
colon [10].
An increase in enteric concentrations of SCFAs is pur-
ported to confer a variety of health benefits, and indi-
vidually each SCFA may elicit positive effects on the 
intestine [4, 59, 60]. Butyrate in particular is an important 
SCFA in the colon. Butyrate is the primary energy source 
for colonocytes, it improves mucosal barrier function, by 
enhancing the expression of proteins involved in tight 
junctions, and induces the development of colonic Treg 
T cells [61–63]. Butyrate is also associated with increas-
ing intestinal mucus production [64–66], and although 
studies are conflicting, many suggest a positive correla-
tion between butyrate presence and mucin secretion. 
Although we did not observe changes in Muc2 expres-
sion in response to diet treatment, we did observe that 
mice consuming the WB-enriched diet exhibited more 
mucus within goblet cells. Of the diet treatments that 
we examined, the WB-enriched diet continuously pro-
duced the highest concentrations of total SCFAs, includ-
ing butyrate. Previous studies have revealed that β-glucan 
can contribute to enhanced mucus secretion in the intes-
tine [67]. Furthermore, others have shown that diets 
enriched for long-chain arabinoxylans and inulin increase 
the concentration of SCFAs in the colons of mice, and 
concomitantly increase host-derived mucins and butyro-
genic bacteria [68]. Although RS fermentation is known 
to increase intestinal butyrate concentrations [14], ara-
binoxylan fractions found in WB can also increase 
butyrogenic bacteria, and contribute to higher butyrate 
concentrations within the colon than would be produced 
via fermentation of RS alone [22]. In this regard, the 
highest concentrations of butyrate were observed in feces 
from human subjects that consumed wheat arabinoxylan 
over a 3-week period [69]. Although we did not observe 
conspicuous effects of RS and WB diet enrichment on 
host metrics in mice without enteritis (e.g. immune 
responses), it is possible that the by-products of DF fer-
mentation could play an important role in maintaining 
physiological homeostasis in the quiescent intestine. This 
suggests that improved intestinal health and growth can 
occur through the maintenance of the physiologic, meta-
bolic, and immunological balance within the intestinal 
mucosa, and would reduce unwanted energy loss from 
enhanced catabolic demands due to ‘physiologic intesti-
nal inflammation’ [70]. Our results of immune modula-
tion in mice afflicted by acute enteritis suggest that DF 
consumption may also contribute to host health in the 
non-inflamed or moderately inflamed colon [10].
An increase in the abundance of mucus-associated bac-
teria in the colon of mice was consistently observed in the 
current study, especially in mice with enteritis. The abun-
dance of bacterial species known to be associated with 
mucus can be indicative of high mucus content within 
the intestine. Mucispirillum shaedleri is recognized as a 
mucus-dwelling bacterium [71, 72]. However, the degree 
and mechanisms by which M. shaedleri degrades mucus, 
and the importance of mucus as an ecological niche for 
this bacterium remains to be elucidated. Alternatively, A. 
muciniphila has been widely reported as a mucin degrader, 
and it utilizes gastric mucin as its main energy source in 
healthy individuals [73, 74]. We observed that the abun-
dance of the mucus-dwelling bacterium, M. schaedleri 
in the proximal and distal colon (mucosa-associated) 
and cecum (ingesta) was decreased in healthy mice con-
suming DFs. Conversely, A. muciniphila abundance was 
increased in the colon of mice administered DFs, and this 
was observed in all mice regardless of their inflammation 
status. This suggests that during infection, the increase in 
A. muciniphila abundance decreases the mucus available 
for colonization by M. schaedleri (i.e. due to increased 
mucus degradation by A. muciniphila). We did not detect 
elevation of Muc2 expression in the distal colon as a func-
tion of diet treatment. It is plausible that other intestinal 
mucins such as MUC4 or MUC5B may have increased in 
(See figure on previous page.) 
Fig. 9 Cladograms identifying bacterial taxa that are differentially abundant and biologically consistent in mice gavaged with PBS (CR−) and inocu-
lated with C. rodentium (CR+), comparing the differences between mice consuming a control (CN) diet, or a diet enriched with wheat bran (WB) 
or resistant starch (RS). a Communities associated with mucosa in the distal colon. b Communities associated with mucosa in the proximal colon. c 
Communities within cecal ingesta. Highlighted taxa represent significantly (P ≤ 0.050) impactful communities within each treatment
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Fig. 10 Proportion of bacterial taxa in the common phyla in mice gavaged with PBS (−) and inoculated with C. rodentium (+) and consuming a 
control (CN) diet, or a diet enriched with wheat bran (WB) or resistant starch (RS). a Bacterial abundance associated with the distal colon. b Bacterial 
abundance associated with mucosa in the proximal colon. c Bacterial abundance in the cecal ingesta. Vertical lines associated with histogram bars 
represent the standard error of the mean (n = 6). ●Different (P ≤ 0.050) relative to the CR+ treatment. #Different (P ≤ 0.100) relative to the CN treat-
ment. *Different (P ≤ 0.050) relative to the CN treatment. **Different (P ≤ 0.010) relative to the CN treatment
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the intestines of mice consuming the DF-enriched diets 
other than MUC2 [67]. The composition, architecture, and 
microbiology of mucus is complex [75, 76], and the impact 
of DFs on the biochemical and microbiological character-
istics of enteric mucus warrants examination.
Microbial community structures in mice with and 
without enteritis
The consumption of DFs altered the structure of bacte-
rial communities in the distal colon, proximal colon, and 
cecum. We observed that enteritis affected communities 
in the distal colon to a greater degree than DF enrichment 
of diets, and mice consuming the RS-enriched diet exhib-
ited an increase in the abundance of Firmicutes, which has 
been previously reported in mice infected with C. roden-
tium [77]. Our experiment also demonstrated that mice 
challenged with C. rodentium had reduced numbers of 
Proteobacteria within the proximal colon, an interesting 
and unexpected observation. Research has shown that 
C. rodentium infection will increase species belonging 
to the Proteobacteria phylum in mice fed standard chow 
diets [77]. The discrepancy between studies suggests that 
components within the diet alter the intestinal microbi-
ota composition. Indeed, investigators showed that diets 
fortified with lavender extract decreased the abundance 
of Proteobacteria in mice infected with C. rodentium 
[77], an observation linked to the exclusion of Proteo-
bacteria by bacteria within the Firmicutes phylum [78]. 
A number of butyrogenic bacteria (e.g. members of the 
Lachnospiraceae and Ruminococcaceae families within 
the Clostridiales order) reside in the colon [79], and 
we observed an increase in the abundance of butyrate-
producing bacteria including Roseburia spp. within the 
Clostridia XIVa group in mice that ingested DF-enriched 
diets. Moreover, diets containing DFs have been shown 
to increase butyrate levels within the intestine; a pro-
cess associated with changes in the composition of the 
microbiota [80]. Intestinal pH may stimulate the growth 
of butyrogenic bacteria [81]. The lower pHs (≈pH 5.5) 
that occur in the cecum and proximal colon due to SCFA 
production has been shown to enhance the growth of bac-
teria in Clostridia cluster IV and Clostridia cluster XIVa 
[82]. Thus, the increases in SCFA concentrations that 
we observed may be due to the increased abundance of 
butyrogenic bacteria in the colon and cecum [57]. We also 
observed that the proximal colon had a greater diversity 
of mucosa-associated bacteria in comparison to the dis-
tal colon. In the proximal colon of mice without enteritis, 
consumption of the RS-enriched diet was associated with 
an increased abundance of Christensenella spp. In con-
trast, the abundance of A. muciniphila was increased in 
mice with enteritis that consumed the RS-enriched diet. 
Both these species have been shown to improve barrier 
function [83], as well as weight maintenance and health 
in human beings [84, 85]. In the cecum of mice without 
acute enteritis that consumed the WB-enriched diet, 
we observed that the abundance of Paraprevotella and 
Clostridium spp. increased, which is similar to obser-
vations reported in human beings [86]. Thus, our data 
indicates that mice fed diets enriched with DFs exhibit 
enhanced growth of bacteria that thrive in low pH envi-
ronments and produce butyrate as a metabolic by-prod-
uct of DF fermentation. Although we did not observe an 
association between SCFA concentration and the inten-
sity of inflammation in the distal colon, the consumption 
of DF did alter the structure of the bacterial community, 
and in particular contributed to the increase in mucus-
associated species in areas of less intense inflammation, 
such as the proximal colon. Furthermore, an increase in 
the abundance of mucus-associated species may be asso-
ciated with the regulation of host growth and weight gain, 
and may contribute to enhancing barrier function and 
maintenance to improve host health [83, 85, 87]. Intestinal 
fermentation is exceptionally complex biochemically and 
ecologically, and varies spatially and temporally within 
the large intestine. Branched-chain fatty acid fermenta-
tion in the distal colon increases ammonia and nitrogen 
substrates that can also affect bacterial community com-
position [31], yet the impacts of nitrogen metabolism 
resulting from fermentation on intestinal health has not 
been extensively studied.
Conclusions
The consumption of DF has been promoted to improve 
intestinal health. In this study, we explored the influence 
of the DFs WB and RS on SCFA production, modulation 
of the intestinal microbiota, and intestinal health using 
a C. rodentium model of colitis in mice [77]. Although 
some differences in responses between RS and WB were 
observed, in general, DF was associated with elevated 
SCFA levels including butyrate within the large intestine, 
and reduced tissue inflammation and enhanced epithe-
lial cell repair in inflamed intestines. DFs were also asso-
ciated with an altered composition of the microbiota, 
favoring an increase in butyrogenic bacteria. Collectively, 
study findings indicate that DFs have the potential to 
improve intestinal health via a number of mechanisms.
Methods
Experimental design
The experiment was designed as a completely rand-
omized design with three levels of diet (CN, RS, and 
WB), two levels of immunological stress (± C. roden-
tium), and three levels of sample time (14, 21, and 28 days 
p.i.). Each replicate included 36 mice, and four replicates 
were conducted on separate occasions (144 animals in 
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total). It is noteworthy that separate mice were used for 
the quantification of SCFAs (n = 18 mice/replicate).
Ethics statement
The study was carried out in strict accordance with the 
recommendations specified in the Canadian Council on 
Animal Care Guidelines. The project was reviewed and 
approved by the Lethbridge Research and Development 
Centre (LRDC) Animal Care Committee (Animal Use 
Protocol Review 1405), and the LRDC Biosafety and 
Biosecurity Committee before commencement of the 
research.
Mouse maintenance
Specific pathogen free C57BL/6J mice were obtained 
from Charles River Laboratories (Montreal, QC) at 
3-weeks of age. For each of the four replicates, mice were 
group-housed with six mice per cage upon arrival, and 
were given 5 days to acclimate under a 10:14 h dark:light 
cycle. After adaptation, mice were individually housed 
and permitted to eat and drink ad  libitum. Cages were 
lined with sterile bedding and housing units, and along 
with the food and water were replaced weekly. Mice were 
monitored daily to confirm their health status [88], and 
initial body weights were taken prior to oral inoculation 
with C. rodentium in PBS (0.01  M NaH2PO4, 0.04  M 
Na2HPO4, 0.07 M NaCl, Sigma-Aldrich; pH 7.4) or PBS 
alone. Body weights were measured at the time of euth-
anization to ascertain total weight gained during the 
experimental period. Feed was also weighed on the day 
of inoculation and at euthanization to determine the total 
weight of food consumed.
Dietary fiber supplementation
Upon arrival at LRDC, mice were maintained on a con-
ventional rodent chow diet. After the 5-day adaptation 
period, mice were switched to experimental diets for a 
period of 14 days prior to inoculation with C. rodentium 
or PBS alone. The basal diet consisted of a modified AIN-
93G purified rodent diet with sterile vitamin free casein 
(DYET#103455GI). For the WB diet, the basal diet was 
enriched with 117  g/kg of Bob’s Red Mill WB (DYET 
#103456GI). For the RS diet, the basal diet was enriched 
with 125 g/kg of King Arthur Flour Hi-Maize® (i.e. type 
2 RS) (DYET#103457GI). The CN diet consisted of the 
basal diet alone. All diets (Bethlehem, PA, USA) were 
color coded with dye (i.e. to ensure accurate administra-
tion), pelleted, vacuum sealed and irradiated, and stored 
at −20 °C for short periods until used.
Citrobacter rodentium inoculation
A green fluorescent protein (GFP)-labelled C. roden-
tium DBS100 (ATCC 51459) was used. The bacterium 
was grown aerobically at 37  °C for 24  h on Lysogeny 
Broth agar (LA) with 30  µg/mL chloramphenicol [65]. 
In a preliminary study, it was determined that neither 
RS or WB affected growth of C. rodentium (data not 
presented). Bacterial cells for inoculation were grown in 
sterile Lysogeny Broth (LB) containing 15  µg/mL chlo-
ramphenicol (Sigma-Aldrich, Oakville, ON) for 2  h at 
37 °C at 100 rpm, until an OD600 > 0.1 was obtained. Cells 
were pelleted by centrifugation at 2256×g for 15 min, the 
supernatant was removed, and cells were re-suspended 
in 3.0  mL of PBS. Cell density and viability was con-
firmed using a tenfold dilution series, and 100 µL of each 
dilution was spread in duplicate onto LA, and cultures 
were incubated at 37  °C. Cell densities were adjusted 
to 2 × 109 CFU/mL with PBS. Eighteen mice were gav-
age inoculated with C. rodentium cells (100 µL) using a 
22G × 2.5 cm-long gavage needle with a 1.25 mm ball tip 
on two consecutive days. Similarly, 18 mice were gavage 
inoculated with PBS alone (100 µL). Animals were moni-
tored for discomfort/pain for 4 h after inoculation using a 
quantitative pain assessment scoring system as specified 
by the LRDC Animal Care Committee.
Isolation of C. rodentium from collected feces
Fecal samples from mice were collected 3, 7, 10, 14, 21, 
and 28 days p.i. Briefly, fecal samples were homogenized 
in PBS, diluted in a tenfold dilution series, and dupli-
cate aliquots (100 µL) of the homogenate were spread on 
MacConkey agar (Becton, Dickinson and Company, Mis-
sissauga, ON) with 15  µg/mL chloramphenicol (Sigma 
Aldrich, Oakville, ON) [65]. After 24  h incubation at 
37  °C, C. rodentium colonies were enumerated and the 
identity of the bacterium isolated (arbitrarily selected 
colonies) was confirmed with colony PCR target-
ing the EspB protein [89]. Primers specific for the espB 
gene, (F:5′-GCTTCTGCGAAGTCTGTCAA-3′, R:5′-
CAGTAAAGCGACTTAACAGATT-3′) were used with 
PCR conditions that commenced with one cycle of 15 s 
at 95 °C, followed by 35 cycles of 45 s at 95 °C, 1 min at 
57 °C, 1 min at 72 °C, and a final cycle of 5 min at 72 °C. 
The amplicon was 270 base pairs (bp) in size.
Animal euthanization and intestinal sample collection
On days 14, 21 and 28 p.i., arbitrarily selected mice from 
each treatment were anesthetised with isoflurane and 
euthanized by cervical dislocation under anesthesia. To 
visualize the intestine and collect samples, a mid-line 
laparotomy was used to exteriorize the intestine [65]. A 
gross pathological assessment of the large intestine with 
photo-documentation was completed, and the length and 
width of the cecum and colon were measured. The cecum 
and colon were longitudinally incised, and luminal con-
tents were collected and stored at −20  °C for DNA 
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extraction and characterization of the microbiota. Sec-
tions of the distal colon were collected and immediately 
placed in RNAlater™ (Qiagen Inc., Toronto, ON) and 
subsequently stored at −20 °C for mRNA extraction. Sec-
tions from the proximal and distal colon were collected 
and frozen for subsequent for DNA analysis. Samples of 
histological examination were placed in Surgipath® 10% 
neutral buffered formalin (Leica Biosystems, Concord, 
ON) for histopathologic scoring, and in Methacarn (60% 
methanol, 30% chloroform, 10% glacial acetic acid) for 
mucus analysis [90].
Histopathologic scoring
Formalin-fixed tissues were dehydrated in increasing 
concentrations of ethanol (80, 95, 100%) at room tem-
perature (RT) and placed in Histo-Clear (Diamed Lab 
Supplies, Mississauga, ON) prior to embedding in par-
affin at 60  °C [65]. Sections  (5  µm) were deparaffinized 
with xylene at RT, and stained with hematoxylin and 
eosin dyes according to a standard protocol. Tissues 
were scored for mucosal damage by a veterinary patholo-
gist blinded to the treatments using an established scor-
ing guide [26] that ranked common characteristics of 
mucosal damage (i.e. epithelial cell injury and hyperpla-
sia, goblet cell depletion, crypt height, mitotic activity, 
and inflammation) from 0 to 4, with 4 being pronounced 
damage and 0 representing minimal to no damage (Addi-
tional file 1: Table S2). The maximum achievable score for 
tissue injury was 22.
Visualization of mucus
To visualize mucus, colonic tissue samples were fixed 
overnight in Methacarn at RT [90], prior to dehydration 
with ethanol and Histo-Clear (Diamed Lab Supplies, Mis-
sissauga, ON). Sections (5 µm) were deparaffinized on a 
60 °C heating bed, cleared with xylene, and rehydrated in 
a decreasing ethanol gradient (100, 90, 70, 50%) accord-
ing to a standard protocol (Abcam, Toronto, ON). For 
mucus visualization, sections were stained with Alcian 
Blue (pH 2.5; American MasterTech, Lodi, CA), followed 
by 0.5% Periodic Acid (American MasterTech, Lodi, CA) 
at RT for 5 min, and Schiff’s solution (American Master-
Tech, Lodi, CA) at 4 °C for 15 min. Slides were examined 
with a Zeiss Axioskop Epifluorescent microscope (Zeiss 
Canada Ltd., Toronto ON).
Short‑chain fatty acid analysis
To quantify SCFAs, the cecum, proximal colon, and distal 
colon were collected from one mouse per treatment per 
replicate. The total weight of the tissue including ingesta 
was recorded, and after removal of the cecum, the colon 
was divided equally into halves as the proximal and dis-
tal colon. SCFAs concentrations were determined as 
described previously [65]. Briefly, sections were homog-
enized in PBS at a 1:9 ratio (w/v). Meta-phosphoric acid 
(Sigma Aldrich, Oakville, ON) was added to the homoge-
nate at a 1:4 ratio (v/v), and incubated at RT for 30 min. 
Samples were centrifuged at RT for 75 min at 16,100×g, 
and the supernatants collected and stored at −20  °C. 
Acetate, butyrate, and propionate concentrations were 
quantified with a gas chromatograph (Agilent Technolo-
gies, Model 6890N with 7683 Series Injector) according 
to established protocols [91, 92].
Characterization of bacterial communities in the cecum, 
and proximal and distal colon
Bacterial genomic DNA was extracted from distal and 
proximal colonic samples (mucosa-associated) using 
QIAGEN® DNeasy Blood and Tissue Extraction kits 
(Qiagen Inc.). Genomic DNA was also extracted from the 
cecal ingesta using the QIAamp® Fast DNA stool extrac-
tion kit (Qiagen Inc.); the entire cecum was removed, 
and all of the ingesta contents were collected for analysis. 
Extracted DNA was processed using an Illumina proto-
col for creating 16S metagenomic sequencing libraries 
[93]. Briefly, extracted DNA was normalized to 5  ng/
µL in 10 mM Tris (pH 8.5) and 2.5 µL was PCR ampli-
fied with 5  µL of each amplicon primer specific for the 




TCTAATCC-3′) and 12.5  µL of 2× KAPA HotStart 
Ready mix for a final volume of 25 µL. A PCR clean-up 
using AMPure XP (Beckman Coulter, Inc.) beads on a 
magnetic stand was performed on the 500 bp products, 
and an indexing PCR was used to add dual indices to 
each sample. Conditions included 5 µL of DNA, 5 µL of 
each index primer (specific non-repeating pair per sam-
ple) and 25 µL of 2× KAPA Hifi HotStart Ready mix and 
nuclease-free water (Qiagen Inc.) to a final volume of 
50 µL per sample. A final PCR clean-up was performed 
on the 630  bp product. The resulting indexed DNA 
libraries were quantified and normalized to 4  nM, and 
5 µL of each normalized library was pooled into one sam-
ple for sequencing using a MiSeq (Illumina, San Diego, 
CA). A PhiX control was run in parallel with the normal-
ized DNA libraries, and both were denatured and diluted 
to 4 pM prior to loading onto the MiSeq cartridge.
Quantitative Insights Into Microbial Ecology (QIIME, 
version 1.9.0) analysis was used to assemble forward 
reads [94]. Barcodes were extracted from each sam-
ple and joined for each library. Libraries were then split, 
and sequences were filtered to include high fidelity 
sequences using the parameters described in [65]. These 
sequences (n  =  1,556,473) were then chimera checked 
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using USEARCH 6.1 software, and the resulting chimeras 
were filtered out prior to picking operational taxonomic 
units (OTU) from the Greengene reference database. In 
total, 1,392,105 OTUs were identified using a 97% simi-
larity parameter, and the most common sequence was 
used to define the groups of similar OTUs. After, OTUs 
were aligned using the NAST algorithm [95] to the Ribo-
somal Database Project classifier of 0.8 (sequences having 
at least 80% similarity to reference database sequences). 
Taxonomy was assigned to each sequence cluster using 
UCLUST [96] and classified using the Greengenes refer-
ence database [97]. An OTU table was produced, and all 
samples were rarified so that 1,250 OTUs were randomly 
chosen from each sample and compared for analysis 
(OTU per biological sample ranged from 1,250 to 57,439). 
Diversity among species (β-diversity) was examined using 
Bray-Curtis, weighted and unweighted Uni-Frac analyses.
Quantification of gene expression
Cytokine expression profiles were generated from total 
RNA that was extracted from colonic tissue using an 
RNeasy® Mini kit (Qiagen Inc.). The concentration and 
quality of the total RNA extracted was analyzed using a 
RNA 600 Nano LabChip on an Agilent 2100 bioanalyzer. 
Using 1000  ng of total RNA, reverse transcription was 
performed using the QuantiTect® Reverse Transcription 
Kit (Qiagen Inc. Toronto, ON). Differential expression 
of 15 genes involved in the Th1, Th17, and Treg immune 
responses were measured, as well as mucus expression, 
and genes involved in bacterial recognition and epithelial 
repair (Additional file 1: Table S3). The primers used were 
uniquely designed using sequence information within 
the NCBI database. Reference genes used to normalize 
measured Ct values were Ppia, Hprt, and GusB [65]. All 
primers were diluted to 10  nM, and high performance 
liquid chromatography purified. Quantitech SYBR Green 
Mastermix (Qiagen Inc.) was used as an indicator of dou-
ble stranded DNA and product amplification. Individual 
PCR consisted of: 1 µL of cDNA; 3 µL of Optima water 
(Fisher Scientific, Edmonton, AB); 0.5  µL of 10  µM for-
ward primer (Additional file 1: Table S3); 0.5 µL of 10 µM 
reverse primer (Additional file 1: Table S3); and 5 µL of 
SYBR green. Reactions were run in triplicate per cDNA 
sample (i.e. treated as observations). Quantitative PCR 
(qPCR) was run on an ABI 7900HT qPCR thermocycler 
(384-well block; Life Technologies, Burlington, ON), with 
an activation step of 95  °C for 15  min, and 40 cycles of 
94 °C for 15 s, 58 °C for 30 s and 72 °C for 30 s, followed 
by 1 cycle of 95 °C for 15 s, 55 °C for 15 s and 95 °C for 
15 s. The mean of the three observations was calculated, 
and normalized gene expression was calculated using 
qbasePLUS (Biogazelle, Zwijnaarde, Belgium) based on 
geNorm and qBase quantification models [98, 99].
Statistical analyses
Most statistical analyses were performed using SAS (SAS 
Institute Inc., Cary, NC). Continuous data was checked 
for normality, and analysed using the MIXED procedure 
of SAS (SAS Institute Inc., Cary, NC). Where applicable, 
collection time was treated as a repeated measure; the 
appropriate covariance structure was utilized according 
to the lowest Akaike’s Information Criterion. In the event 
of a significant main effect, the least squares means test 
(LSM) was used to compare treatments within factors. 
Probability values ≤0.050 were considered to be statis-
tically significant, whereas P values >0.050 and ≤0.100 
were considered to be a significant trend. For bacte-
rial community data, both SAS and Primer 7 were used 
to analyze data. In Primer 7, PERMANOVA and princi-
pal coordinates analyses (PCoA) were used to analyze 
the β-diversity, whereas, analyses of variance (MIXED 
procedure) with a protected LSM test were used to ana-
lyze α-diversity. Differences in the abundance of bacte-
rial OTUs were also analyzed using analysis of variance 
(ANOVA) with a protected LSM test, and P values ≤0.100 
were deemed statistically significant. A one-way ANOVA 
with a Wilcoxon two sample test for location differences, 
as well as the Kruskal–Wallace test was used to analyze 
significance between diet treatments for the histopatho-
logic, gene expression, and LEfSe sequencing data.
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